DETECT Nitazenes Act of 2025

Legislative Summary: DETECT Nitazenes Act of 2025

Overview

The DETECT Nitazenes Act of 2025 (S. 3093) is a targeted legislative effort to enhance the United States' ability to identify and intercept nitazenes—a class of potent synthetic opioids—at national borders and points of entry. By updating existing statutory language, the bill ensures that federal agencies have the legal mandate to evaluate and deploy technology specifically designed to detect these dangerous substances.

Purpose and Intent

The primary intent of this bill is to counter the evolving threat of synthetic opioids. As illicit drug traffickers shift toward new chemical compounds like nitazenes (which can be significantly more potent than fentanyl), the federal government must update its detection capabilities. This bill seeks to formalize the inclusion of nitazenes in the scope of homeland security technology evaluations.

Key Provisions

The bill is concise and achieves its goal through a specific amendment to existing law:

• Amendment to the Homeland Security Act of 2002: The bill amends Section 302(15) of the Homeland Security Act of 2002 (6 U.S.C. 182(15)).
• Expanded Scope of Detection: It updates the list of targeted substances. Previously, the law specifically highlighted fentanyl and xylazine. The Act adds nitazenes to this list, effectively mandating that the detection equipment and technology evaluations performed by the government include the ability to identify nitazenes.

Who is Affected?

• Homeland Security / Customs and Border Protection (CBP): These agencies will be responsible for evaluating and implementing the technology required to detect nitazenes.
• Public Health and Safety: By increasing the detection rate of nitazenes at the border, the bill aims to reduce the volume of these potent synthetic opioids entering domestic communities, potentially lowering overdose rates.
• Technology Developers: Companies creating sensing and detection equipment for the federal government will now have a formal requirement to ensure their tech can identify nitazenes.

Procedural Status

• Introduced: November 3, 2025
• Current Status: The bill has been read twice and referred to the Committee on Homeland Security and Governmental Affairs.
• Bipartisan Support: The bill features co-sponsorship from a diverse group of senators, indicating broad legislative support for addressing the synthetic opioid crisis.